ANEB Market Cap History
Below is a table of the ANEB market cap history going back to 5/7/2021:

Date ANEB Market Cap
5/7/2021165.19M
6/16/2021178.12M
9/15/2021161.66M
11/12/2021145.90M
2/11/2022156.18M
5/10/202281.71M

Also see: ANEB Shares Outstanding History
and ANEB YTD Return
ANEB Historical Market Cap:
-50.25% CAGR
ANEB Historical Market Cap: +-50.25% CAGR

Mouse over chart for data details
5/7/20216/16/20219/15/202111/12/20212/11/20225/10/2022
Anebulo Pharmaceuticals is a clinical-stage biotechnology company developing solutions for people suffering from acute cannabinoid intoxication (ACI) and addiction. Co.'s primary product candidate is ANEB-001, a small molecule cannabinoid receptor antagonist, to address the unmet medical need for an antidote for ACI. ANEB-001 is an orally bioavailable absorbed treatment that will reverse the symptoms of ACI. Co.'s proprietary position in the treatment of ACI is protected by rights to several patent applications covering various methods of use of the compound and delivery systems. We show 6 historical shares outstanding datapoints in our ANEB shares outstanding history coverage, used to compute ANEB market cap on those dates.

Understanding the changing numbers of shares outstanding, the changing share price, and the resulting changing ANEB market cap history over the course of time is important for investors interested in comparing ANEB's market cap history versus its peers. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies, and then calculating their respective market caps. Comparing the share price of ANEB versus a peer is one thing; comparing ANEB market cap versus a peer is a completely different story. Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares), the market cap for a company like ANEB can fluctuate over the course of history. With this page we aim to empower investors researching ANEB by allowing them to research the ANEB market cap history.
Quotes delayed 20 minutes

Email EnvelopeFree ANEB Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold Stocks in the S&P
10 Most Overbought Stocks in the S&P
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: The Importance of Market Cap


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Anebulo Pharmaceuticals (ANEB) is categorized under the Healthcare sector; to help you further research historical market cap numbers, below are some other companies in the same sector:

ANGN Market Cap History
ANGO Market Cap History
ANIK Market Cap History
ANIP Market Cap History
ANIX Market Cap History
ANNX Market Cap History
ANTH Market Cap History
ANVS Market Cap History
APDN Market Cap History
APEN Market Cap History
More Healthcare companies »

 

ANEB Market Cap History | www.MarketCapHistory.com | Copyright © 2017 - 2022, All Rights Reserved

Nothing in MarketCapHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.